S2Medical (Sweden) Performance

S2M Stock  SEK 0.01  0.0003  2.75%   
On a scale of 0 to 100, S2Medical holds a performance score of 3. The firm has a beta of -0.74, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning S2Medical are expected to decrease at a much lower rate. During the bear market, S2Medical is likely to outperform the market. Please check S2Medical's semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether S2Medical's existing price patterns will revert.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in S2Medical AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, S2Medical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow25.3 M
Total Cashflows From Investing Activities-3 M
Free Cash Flow-22.8 M
  

S2Medical Relative Risk vs. Return Landscape

If you would invest  1.02  in S2Medical AB on November 12, 2025 and sell it today you would earn a total of  0.04  from holding S2Medical AB or generate 3.92% return on investment over 90 days. S2Medical AB is generating 0.2459% of daily returns assuming 6.2536% volatility of returns over the 90 days investment horizon. Simply put, 56% of all stocks have less volatile historical return distribution than S2Medical, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon S2Medical is expected to generate 7.72 times more return on investment than the market. However, the company is 7.72 times more volatile than its market benchmark. It trades about 0.04 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

S2Medical Target Price Odds to finish over Current Price

The tendency of S2Medical Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.01 90 days 0.01 
about 40.56
Based on a normal probability distribution, the odds of S2Medical to move above the current price in 90 days from now is about 40.56 (This S2Medical AB probability density function shows the probability of S2Medical Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon S2Medical AB has a beta of -0.74. This usually implies as returns on the benchmark increase, returns on holding S2Medical are expected to decrease at a much lower rate. During a bear market, however, S2Medical AB is likely to outperform the market. Additionally S2Medical AB has an alpha of 0.07, implying that it can generate a 0.07 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   S2Medical Price Density   
       Price  

Predictive Modules for S2Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as S2Medical AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.016.31
Details
Intrinsic
Valuation
LowRealHigh
0.000.016.31
Details

S2Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. S2Medical is not an exception. The market had few large corrections towards the S2Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold S2Medical AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of S2Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.07
β
Beta against Dow Jones-0.74
σ
Overall volatility
0.0008
Ir
Information ratio -0.01

S2Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of S2Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for S2Medical AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
S2Medical AB had very high historical volatility over the last 90 days
S2Medical AB has some characteristics of a very speculative penny stock
S2Medical AB has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 7.7 M. Net Loss for the year was (20.08 M) with profit before overhead, payroll, taxes, and interest of 7.42 M.
S2Medical AB has accumulated about 32.15 M in cash with (19.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 38.0% of the company outstanding shares are owned by corporate insiders

S2Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of S2Medical Stock often depends not only on the future outlook of the current and potential S2Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. S2Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding107.5 M
Cash And Short Term Investments9.5 M

S2Medical Fundamentals Growth

S2Medical Stock prices reflect investors' perceptions of the future prospects and financial health of S2Medical, and S2Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on S2Medical Stock performance.

About S2Medical Performance

Assessing S2Medical's fundamental ratios provides investors with valuable insights into S2Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the S2Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
S2Medical AB develops, produces, and sells wound healing products for burns and chronic wounds. The company was founded in 2013 and is headquartered in Linkping, Sweden. S2Medical is traded on Stockholm Stock Exchange in Sweden.

Things to note about S2Medical AB performance evaluation

Checking the ongoing alerts about S2Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for S2Medical AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
S2Medical AB had very high historical volatility over the last 90 days
S2Medical AB has some characteristics of a very speculative penny stock
S2Medical AB has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 7.7 M. Net Loss for the year was (20.08 M) with profit before overhead, payroll, taxes, and interest of 7.42 M.
S2Medical AB has accumulated about 32.15 M in cash with (19.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 38.0% of the company outstanding shares are owned by corporate insiders
Evaluating S2Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate S2Medical's stock performance include:
  • Analyzing S2Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether S2Medical's stock is overvalued or undervalued compared to its peers.
  • Examining S2Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating S2Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of S2Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of S2Medical's stock. These opinions can provide insight into S2Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating S2Medical's stock performance is not an exact science, and many factors can impact S2Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for S2Medical Stock Analysis

When running S2Medical's price analysis, check to measure S2Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy S2Medical is operating at the current time. Most of S2Medical's value examination focuses on studying past and present price action to predict the probability of S2Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move S2Medical's price. Additionally, you may evaluate how the addition of S2Medical to your portfolios can decrease your overall portfolio volatility.